KIMBERLY ORLECK: Open Payments
NPI 1952632580 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176,791 in 307 payments from 11 companies in 2025. Trend: 2023 $192,062 · 2024 $177,819 · 2025 $176,791
Speaker / faculty: $130,287Consulting: $29,580Travel & lodging: $12,579Food & beverage: $4,260Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 92 | $71,754 |
| ABBVIE INC. | 107 | $54,295 |
| PFIZER INC. | 24 | $20,584 |
| Lilly USA, LLC | 15 | $11,382 |
| Phathom Pharmaceuticals, Inc. | 12 | $6,663 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $4,428 |
| Ardelyx, Inc. | 24 | $3,407 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $3,357 |
| GENZYME CORPORATION | 1 | $882 |
| Celltrion USA Inc. | 1 | $20 |
Products named: TREMFYA, VELSIPITY, SKYRIZI, RINVOQ, OMVOH, VOQUEZNA, VIBERZI, LINZESS.
Industry payments across GA — which companies pay providers there.
